Gene · 1548
Papers4,152
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,152
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Down-Regulation of CYP3A4 by the KCa1.1 Inhibition Is Responsible for Overcoming Resistance to Doxorubicin in Cancer Spheroid Models. | Int J Mol Sci | 2023 | 37958656 | PubTator, text mining | PubMed |
| Electroencephalography as a diagnostic tool for late-onset efavirenz neurotoxicity syndrome. | PLoS One | 2023 | 37948398 | PubTator, text mining | PubMed |
| Role of intravenous ketamine in the pathogenesis of secondary sclerosing cholangitis in critically ill patients: perpetrator or innocent bystander? Answers provided by forensic toxicology. | Intensive Care Med | 2023 | 37943301 | PubTator, text mining | PubMed |
| Dexmedetomidine in the Treatment of Depression: An Up-to-date Narrative Review. | Clin Pract Epidemiol Ment Health | 2023 | 37916205 | PubTator, text mining | PubMed |
| Prognostic model of hepatocellular carcinoma based on cancer grade. | World J Clin Cases | 2023 | 37900243 | PubTator, text mining | PubMed |
Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy. | Pharmaceutics | 2023 | 37896215 | PubTator, text mining | PubMed |
| Taming Postoperative Delirium with Dexmedetomidine: A Review of the Therapeutic Agent's Neuroprotective Effects following Surgery. | Pharmaceuticals (Basel) | 2023 | 37895924 | PubTator, text mining | PubMed |
| Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide. | Int J Mol Sci | 2023 | 37894954 | PubTator, text mining | PubMed |
| The Strange Case of Orotic Acid: The Different Expression of Pyrimidines Biosynthesis in Healthy Males and Females. | J Pers Med | 2023 | 37888054 | PubTator, text mining | PubMed |
| Oral ketamine may offer a solution to the ketamine conundrum. | Psychopharmacology (Berl) | 2023 | 37882811 | PubTator, text mining | PubMed |
| Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline. | Front Pharmacol | 2023 | 37860115 | PubTator, text mining | PubMed |
| The effect of brain serotonin deficit (TPH2-KO) on the expression and activity of liver cytochrome P450 enzymes in aging male Dark Agouti rats. | Pharmacol Rep | 2023 | 37848703 | PubTator, text mining | PubMed |
| A quest for the stereo-electronic requirements for selective agonism for the neurotrophin receptors TrkA and TrkB in 17-spirocyclic-dehydroepiandrosterone derivatives. | Front Mol Neurosci | 2023 | 37840771 | PubTator, text mining | PubMed |
| Nicotine: From Discovery to Biological Effects. | Int J Mol Sci | 2023 | 37834017 | PubTator, text mining | PubMed |
| A systematic study of key elements underlying molecular property prediction. | Nat Commun | 2023 | 37833262 | PubTator, text mining | PubMed |
| The crosstalk between non-coding RNA polymorphisms and resistance to lung cancer therapies. | Heliyon | 2023 | 37829813 | PubTator, text mining | PubMed |
| Association between the oxidative stress gene polymorphism and chronic obstructive pulmonary disease risk: a meta-analysis. | BMC Pulm Med | 2023 | 37817181 | PubTator, text mining | PubMed |
| Redundant and scattered genetic determinants for coumarin biodegradation in Pseudomonas sp. strain NyZ480. | Appl Environ Microbiol | 2023 | 37815346 | PubTator, text mining | PubMed |
| Binding characteristics of pyrrole-scaffold hepatitis B virus capsid inhibitors and identification of novel potent compounds. | RSC Adv | 2023 | 37807973 | PubTator, text mining | PubMed |
| Effect of nivasorexant (ACT-539313), a selective orexin-1-receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects. | Pharmacol Res Perspect | 2023 | 37800597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1548/papers?page=9